Department of the Army, DoD.
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/252,675 entitled “Enhanced Substrates for the Protease Activity of Serotype a Botulinum Neurotoxin,” filed October 18, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
The invention relates to the use of enhanced substrates for the protease activity of serotype A botulinum neurotoxin.Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E9-26787 Filed 11-5-09; 8:45 am]
BILLING CODE 3710-08-P